{"slideshow_credits": null, "snippet": "Endo&#8217;s offer of $175 a share in cash and stock, or about $11.2 billion, trumps the $158 a share all-cash deal Valeant reached with Salix last month.", "abstract": "Endo International offers $175 a share in cash and stock to acquire Salix Pharmaceuticals, which values company at around $11.2 billion, trumping around $10 billion bid made by Valeant Pharmaceuticals; offer complicates what would have been straightforward sale for Salix.", "section_name": "Business Day", "print_page": "8", "document_type": "article", "byline": {"person": [{"firstname": "David", "role": "reported", "lastname": "GELLES", "rank": 1, "organization": ""}], "original": "By DAVID GELLES"}, "web_url": "http://www.nytimes.com/2015/03/12/business/dealbook/endo-is-said-to-make-bid-for-salix-pharmaceuticals-that-tops-rival-offer.html", "lead_paragraph": "Endo&#8217;s offer of $175 a share in cash and stock, or about $11.2 billion, trumps the $158 a share all-cash deal Valeant reached with Salix last month.", "headline": {"main": "Endo Confirms Bid for Drug Maker Salix, Topping Offer From Valeant", "print_headline": "Endo Confirms Bid for Drug Maker Salix, Topping Offer From Valeant"}, "_id": "550083db38f0d85f331bf8c5", "word_count": "694", "multimedia": [], "pub_date": "2015-03-12T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "organizations", "value": "Endo International PLC", "is_major": "Y", "rank": "1"}, {"name": "organizations", "value": "Salix Pharmaceuticals Ltd", "is_major": "Y", "rank": "2"}, {"name": "organizations", "value": "Valeant Pharmaceuticals International Inc", "is_major": "Y", "rank": "3"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "is_major": "N", "rank": "4"}], "blog": [], "subsection_name": "DealBook", "type_of_material": "News"}